Following two recent proposals put to shareholders in early December, Aquis-listed investment company Greencare Capital PLC (AQSE:GRE) said it has got agreement to pivot its investment strategy away from cannabis and CBD companies.
At a general meeting held in London, shareholders also voted to change the company’s name to MaxRets Ventures PLC. Greencare said it will accordingly make to necessary applications to Companies House.
Greencare’s board earlier stated that the CBD sector had underperformed and that novel food legislation developments in the UK, while helping to provide clarity, would likely cause short to medium-term turbulence in the market.
The board has identified pre-IPO life sciences, cryptocurrency, impact and retail as key opportunities.
Greencare said that “the company's underlying investment driver will be technology-driven businesses based on their potential future value enhancement and investment returns”.
Further updates will be given in due course, it added.